OpGen Inc

Change company Symbol lookup

Select an option...

OPGN OpGen Inc

THAR Tharimmune Inc

KITT Nauticus Robotics Inc

EAT Brinker International Inc

JCSE JE Cleantech Holdings Ltd

GVP GSE Systems Inc

CURV Torrid Holdings Inc

APRN Blue Apron Holdings Inc

BXRX Baudax Bio Inc

LAC Lithium Americas Corp

Go

OpGen, Inc. (OpGen) is a precision medicine company that uses molecular diagnostics and informatics to combat infectious diseases. The Company, through its subsidiaries, is focused on developing and commercializing molecular microbiology solutions helping to guide clinicians with actionable information infections caused by multidrug-resistant microorganisms (MDROs). The Company’s product portfolio includes Unyvero, Acuitas AMR Gene Panel, and the ARES Technology Platform including ARESdb, next-generation sequencing (NGS) technology and AI-powered bioinformatics solutions for AMR surveillance, outbreak analysis, and antibiotic response prediction including ARESiss, ARESid, ARESasp, and AREScloud, as well as the Curetis CE- in vitro diagnostics (IVD)-marked polymerase chain reaction (PCR)-based severe acute respiratory syndrome (SARS)-CoV-2 test kit. The Company’s subsidiaries include Curetis GmbH and Ares Genetics GmbH.